This is a crucial step that Affluent Medical, one of the French nuggets of the medical device, is preparing to take.
This young company, founded three years ago by the Truffle Capital fund, announces its IPO.
The start of listing could take place between now and mid-May.
With three devices currently in clinical development, Affluent Medical "needed funding that only the Stock Exchange could provide [it]", explains Michel Finance, its CEO, who was the first boss of Carmat, the inventor of the artificial heart. .
Read also: Medical devices: the medtech Affluent Medical raises 10 million euros
The big leagues
Three years ago, when the company - resulting from the merger of four medtechs - had just been created, it had to give up its listing because of "
difficult market conditions
" and undoubtedly timing. premature.
Affluent Medical, specialist in minimally invasive implants for the treatment of cardiac and urological pathologies, intends to play well in the big league, American and British
This article is for subscribers only.
You have 71% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in
